Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Rozanolixizumab in Adult Participants With Ocular Myasthenia Gravis [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating the efficacy and safety of Rozanolixizumab for ocular myasthenia gravis in adults is listed as NOT_YET_RECRUITING.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ocular Myasthenia Gravis

Drugs mentioned

• Rozanolixizumab

Snippet

Sponsor: UCB Biopharma SRL | Conditions: Ocular Myasthenia Gravis | Phase 3 | Status: NOT_YET_RECRUITING